ArticleLeukemia2026

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Mouhamad Khouja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.